Advocate Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Advocate Group's ABBV Position: Q2 2026 in Review
Advocate Group reduced its AbbVie (ABBV) stake by 0.8% in Q2 2026, selling an estimated $130K and leaving 75,067 shares worth $18.9M. The position accounts for 2.84% of the portfolio, ranked #3.
Advocate Group first reported a position in ABBV in Q2 2022 and has held it in 17 quarters since. The position peaked at $19M in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Advocate Group held 75,067 shares of AbbVie worth $18.9M as of Q2 2026.
- Advocate Group sold 605 AbbVie shares in Q2 2026, an estimated $130K.
- AbbVie made up 2.84% of Advocate Group's portfolio in Q2 2026, its #3 holding.
- Advocate Group first reported a position in AbbVie in Q2 2022 and has held it in 17 quarters since.
- Advocate Group's AbbVie position peaked at $19M in Q3 2025.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.